Mazor Robotics Ltd (TASE:MZOR), the leader in innovative surgical robots and complementary products for spine surgery, announced that Tri-City Medical Center in Oceanside, California, purchased its Renaissance™ system. Mazor launched Renaissance in 2011 as its next generation surgical guidance system for spine procedures.
Located in the North San Diego County community of Oceanside, California since 1961, Tri-City Medical Center is a 397-bed, full-service healthcare facility offering comprehensive medical care. Community owned and operated, Tri-City Medical is nationally recognized for its highly rated, compassionate medical and professional staff and state-of-the-art technology.
The Orthopaedic & Spine Institute at Tri-City Medical specializes in minimally invasive spine surgeries and other spine procedures, such as laminectomy and fusion.
"Surgical robots are changing the surgical landscape, and Tri-City is committed to providing its community with the best technology available," said Larry Anderson, Chief Executive Officer of Tri-City Medical Center. "We intend to become the regional hub of robotically integrated surgical procedures."
"Mazor's impressive technology will create a significant shift in our approach to spinal surgeries," said Dr. Neville Alleyne, orthopedic surgeon at Tri-City.
"We are very excited to have this installation in Southern California, our first in this key market," said Ori Hadomi, CEO of Mazor Robotics. "We have ten active systems in the U.S., including Tri-City and others in Houston, Dallas, and Atlanta. Our U.S. sales team has exciting momentum and we are looking forward to a strong year."
About Mazor Robotics
Mazor Robotics Ltd (TASE: MZOR) is dedicated to the development and marketing of innovative surgical robots and complementary products that provide a safer surgical environment for patients, surgeons, and OR staff. Mazor Robotics' flagship product, Renaissance™, is a state-of-the-art surgical guidance system that enables surgeons to conduct spine surgeries in an accurate and secure manner. Mazor Robotics systems have been successfully used in the placement of over 15,000 implants in the USA and Europe. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability, and clinical advantages of Mazor Robotics technology. For more information, visit www.mazorrobotics.com
Contacts:
U.S. Contacts:
EVC Group
Greg Gin or Doug Sherk,
646-445-4801 (Investors)
Steve DiMattia, 646-201-5445 (Media)
